Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ingevity (NGVT) Invested Capital (2016 - 2025)

Historic Invested Capital for Ingevity (NGVT) over the last 11 years, with Q3 2025 value amounting to $240.1 million.

  • Ingevity's Invested Capital fell 2382.61% to $240.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.1 million, marking a year-over-year decrease of 2382.61%. This contributed to the annual value of $256.5 million for FY2024, which is 6416.6% down from last year.
  • According to the latest figures from Q3 2025, Ingevity's Invested Capital is $240.1 million, which was down 2382.61% from $215.4 million recorded in Q2 2025.
  • Ingevity's Invested Capital's 5-year high stood at $1.0 billion during Q1 2022, with a 5-year trough of $215.4 million in Q2 2025.
  • Its 5-year average for Invested Capital is $578.0 million, with a median of $664.0 million in 2021.
  • In the last 5 years, Ingevity's Invested Capital surged by 4776.67% in 2022 and then plummeted by 6416.6% in 2024.
  • Ingevity's Invested Capital (Quarter) stood at $693.4 million in 2021, then rose by 0.84% to $699.2 million in 2022, then grew by 2.37% to $715.8 million in 2023, then tumbled by 64.17% to $256.5 million in 2024, then decreased by 6.39% to $240.1 million in 2025.
  • Its last three reported values are $240.1 million in Q3 2025, $215.4 million for Q2 2025, and $295.0 million during Q1 2025.